MTOR antibody (AA 1766-2144)
Quick Overview for MTOR antibody (AA 1766-2144) (ABIN2625784)
Target
See all MTOR (mTOR) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 1766-2144
-
Specificity
- Human MTOR
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Human recombinant protein fragment corresponding to amino acids 1766-2144 of human MTOR(NP_004949) produced in E. coli.
Type of Immunogen: Recombinant protein -
Isotype
- IgG1
-
-
-
-
Application Notes
- Approved: IHC, IHC-P (1:150), WB (1:2000)
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.3, 1 % BSA, 50 % glycerol, 0.02 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Minimize freezing and thawing.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Avoid freeze-thaw cycles.
-
-
- MTOR (mTOR) (Mechanistic Target of Rapamycin (serine/threonine Kinase) (mTOR))
-
Alternative Name
- MTOR
-
Background
-
Name/Gene ID: MTOR
Subfamily: PI3/PI4
Family: Protein Kinase
Synonyms: MTOR, FRAP1, FRAP2, FRAP, Mammalian target of rapamycin, RAFT1, Rapamycin and FKBP12 target 1, RAPT1, Rapamycin target protein 1 -
Gene ID
- 2475
-
NCBI Accession
- NP_004949
-
Pathways
- PI3K-Akt Signaling, RTK Signaling, AMPK Signaling, Interferon-gamma Pathway, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Regulation of Actin Filament Polymerization, Regulation of Muscle Cell Differentiation, Regulation of Cell Size, Skeletal Muscle Fiber Development, Regulation of Carbohydrate Metabolic Process, Autophagy, CXCR4-mediated Signaling Events, BCR Signaling, Warburg Effect
Target
-